Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add filters








Year range
1.
Indian J Ophthalmol ; 2019 Dec; 67(12): 1929
Article | IMSEAR | ID: sea-197691
2.
Indian J Ophthalmol ; 2019 Dec; 67(12): 1926-1928
Article | IMSEAR | ID: sea-197680
3.
Indian J Ophthalmol ; 2019 Jul; 67(7): 1234-1235
Article | IMSEAR | ID: sea-197413

ABSTRACT

A 10-year-old boy admitted for high-grade fever and pneumonia developed left preseptal and early orbital cellulitis, unresponsive to higher intravenous antibiotics. He received oseltamivir, on testing positive for H1N1 virus on the nasopharyngeal and throat swabs. There was dramatic improvement with resolution of orbital cellulitis within 24 h of starting oseltamivir. We report a very rare presentation of pediatric orbital cellulitis secondary to systemic H1N1 infection. Prompt investigations and timely treatment with oseltamivir aided in complete resolution, avoiding vision and life-threatening complications.

4.
Indian J Ophthalmol ; 2019 Jun; 67(6): 740-754
Article | IMSEAR | ID: sea-197323

ABSTRACT

Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery chemotherapy or chemosurgery, is currently widely accepted as one of the primary treatment modalities for intraocular retinoblastoma worldwide. Following the introduction of the technique in 1998, IAC has evolved over the past decades to be safer and more effective. Accumulated evidence shows that IAC is more effective in providing eye salvage in group D and E retinoblastoma as compared to conventional systemic intravenous chemotherapy (IVC). In contrast to IVC, IAC has the added benefits of reduced overall treatment duration and minimal systemic toxicity. This review provides a comprehensive update on the history, technique, indications, contraindications, and outcome of IAC. We have also identified the strengths, weaknesses, opportunities and threats (SWOT analysis) of the technique in this review.

5.
Indian J Ophthalmol ; 2019 Jun; 67(6): 958-960
Article | IMSEAR | ID: sea-197311

ABSTRACT

We report a case of non-familial, sporadic fetal retinoblastoma (RB) that was accidently detected at 39 weeks of gestation on pre-natal ultrasonography in left eye (OS). Post-natal examination revealed Group A and, Group D RB in right eye (OD) and OS, respectively. At 35 days, selective ophthalmic artery intra-arterial chemotherapy (IAC) was performed in OS and laser for OD. Pre-natal ultrasound and its application in RB are limited to those cases with a strong genetic predisposition. Our case was accidently detected at late gestation with no familial or genetic predisposition. In addition, this was the youngest reported case that received IAC on literature review.

6.
Indian J Ophthalmol ; 2018 Feb; 66(2): 189
Article | IMSEAR | ID: sea-196602
7.
Indian J Ophthalmol ; 2018 Jan; 66(1): 9
Article | IMSEAR | ID: sea-196566
8.
Indian J Ophthalmol ; 2018 Jan; 66(1): 7-8
Article | IMSEAR | ID: sea-196555
SELECTION OF CITATIONS
SEARCH DETAIL